GlassScriptPhysician profile
Allyson Connor
NPI 1750745832
$23,279.52
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $15K · 2021: $8,051 · 2022: $45.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,500.00 | 2020-2021 | |
| Medtronic USA, INC. | $10,000.00 | 2020 | |
| Medtronic, INC. | $550.74 | 2021 | |
| Alexion Pharmaceuticals, INC. | $56.42 | 2019 | |
| Csl Behring | $52.35 | 2019-2020 | |
| Ethicon US, LLC | $45.33 | 2022 | |
| Genentech USA, INC. | $35.36 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $15.61 | 2020 | |
| Portola Pharmaceuticals, LLC | $11.92 | 2020 | |
| Avanir Pharmaceuticals, INC. | $11.79 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.